U.S. officials have approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated with opioids.

Members of the family who own OxyContin maker Purdue Pharma, and the company itself, agreed to pay up to $7.4 billion in a new settlement to lawsuits over the toll of the powerful prescription ...

Purdue was instrumental in creating the US opioid crisis via aggressive marketing that did not reflect the true addiction ...

Under the new proposal, like the previous one, members of the Sackler family would also give up ownership of Purdue ... family from civil lawsuits over OxyContin — even though the family ...

Opioid abuse tells a tragic American story since avoidable deaths began in the 1990s. Nearly 700,000 people lost their lives ...

Last week’s settlement that would see Purdue Pharma and its owners, the Sackler family, pay $7.4 billion to resolve lawsuits filed by state and local governments across the country is ...

Multiple states have reached a tentative new agreement with the Sackler family, who made billions of dollars marketing OxyContin, the drug that set off the U.S. opioid crisis. New York State Attorney ...

The wheels of justice can grind slowly, especially when large amounts of money are involved, but justice of some sort is ...

Megan Giles Cooney is a writer and artist, who is a summer resident of Northport. Reach her at [email protected].

Last week, members of the Sackler family, which owns the pharmaceutical company known for selling OxyContin, agreed to a $7.4 ...

Paul Howe, chief commercial officer at Protega Pharma, discusses recent rule changes and how the industry is impacted by them ...